Onc Now | Episode 17
In this episode of the Onc Now Podcast, host Jonathan Sackier is joined by Joan Carles, Head of Section for the Genitourinary, Central Nervous System, Sarcomas and Tumours of Unknown Origin Unit at Vall d’Hebron University Hospital. Carles discusses breakthroughs in genitourinary cancer and sarcoma treatment, including anti-angiogenic therapies, overcoming resistance, and the role of genetic polymorphisms in personalised medicine.
Apple | Spotify | Amazon Music | Youtube | Download MP3 (21 mins)
Joan Carles is Head of Section for the Genitourinary, Central Nervous System, Sarcomas and Tumours of Unknown Origin Unit at Vall d’Hebron University Hospital in Barcelona, Spain.
He is additionally Co-Founder of the Spanish Society for the Treatment of Genitourinary Cancer (SOGUG), for which he also served as Secretary and Vice-President, and member of the Spanish Sarcoma Research Group (GEIS). Carles’ pioneering research focuses on genitourinary clinical oncology, sarcoma, and early clinical and translational research.
Timestamps:
00:00 – Introduction
01:56 – Anti-angiogenic therapies
05:03 – Treatment resistance
07:53 – Genetic polymorphisms
09:02 – Sarcoma treatments
11:16 – Novel drugs
15:22 – Oncology societies
18:00 – Carles’ three wishes for healthcare
